Pfizer
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial
14 Oct 2025
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 HER2CLIMB-05 trial of first-line combination therapy with the tyrosine kinase inhibitor TUKYSA ® (tucatinib) in patien
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025
13 Oct 2025
Pfizer Inc. (NYSE: PFE, “Pfizer”) will present data across its infectious disease portfolio at the upcoming IDWeek 2025 congress, held in Atlanta from October 19-22, 2025. Data in 46 abstracts from co
Pfizer Declares Fourth-Quarter 2025 Dividend
10 Oct 2025
Board of Directors approves quarterly cash dividend of $0.43 per share Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 fourth-quarter 2025 dividend on the company’
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
03 Oct 2025
Voluntary agreement meets the President’s four requests while also protecting the U.S. ecosystem responsible for America’s leadership in delivering medical breakthroughs Agreement provides certainty f
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
25 Sep 2025
More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines and potential of next-generation pipeline Pfizer Inc
Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts
23 Sep 2025
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, November 4, 2025. The purpo
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
22 Sep 2025
Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valued at $47.50 per Metsera share in cash upon closing, for an init
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
12 Sep 2025
Phase 3 clinical trial cohort of adults 65+ and 18-64 with at least one underlying risk condition shows at least a 4-fold increase in LP.8.1-neutralizing antibody titers after receiving the LP.8.1-ada
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
01 Sep 2025
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will be
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
12 Aug 2025
PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder c
Featured
Typewriters, the office machines that preceded computers
By Kiron Kasbekar | 10 Apr 2025
You see office tables today equipped with desktop computers or laptops. But think of the 1970s, and what would you have been seeing?
Wishful thinking about cars
By Kiron Kasbekar | 05 Apr 2025
Donald Trump may be many things, but a good economist he is not. Accustomed to dictating terms to people he has worked with,
The history of safety glass
By Kiron Kasbekar | 26 Mar 2025
You probably already knew that the world’s VIPs move around in cars with bullet-proof glass windscreen and windows. But did you know that ‘bulletproof glass’ is not really bulletproof?
German silver: used in cutlery, music, electricals - but it’s not silver
By Kiron Kasbekar | 20 Mar 2025
This material, which was first developed in China, not Germany, and is an alloy of copper, nickel and zinc, has lost its sheen in home uses, but finds favor in electrical engineering.
Pioneers – the Wrights and Glenn Curtiss launched the aircraft industry
By Kiron Kasbekar | 17 Mar 2025
First Orville and Wilbur Wright flew their plane, the ‘Wright Flyer’, from near a small town called Kitty Hawk. Then Glenn Curtiss built planes with a very different system of controls, which has lasted until now.
What do aircraft have in common with bicycles and motorcycles?
By Kiron Kasbekar | 17 Mar 2025
From chains and sprockets to direct drives—If someone asked you what aircraft have in common with bicycles and motorcycles, how would you respond?
Radar’s ancestors: From sound mirrors to modern detection technology
By Kiron Kasbekar | 11 Mar 2025
Radar has become a well-settled technology today, especially in the field of navigation.
Nokia Bell Labs: innovations in communication, computing, technology
By Omar Almeida | 08 Mar 2025
Bell Laboratories, or Bell labs, which has now become Nokia Bell Labs, is one of the most renowned research and development organizations in the history of science and technology.
Company story – Quaker Oats
By Kiron Kasbekar | 08 Mar 2024
Quaker Oats is a company whose products I remember from my childhood days. Years before a foreign exchange crisis caused the Indian government to impose curbs on consumer product imports, we used to see a host of foreign brands in the Indian market. Including Quaker Oats, which I remember eating when I was a child, and which has been available for the past two decades or more.
